Invus Global Management, LLC - 29 Aug 2025 SCHEDULE 13G Report for vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share
Symbol
VTVT
Shares outstanding
3,484,314 shares
Disclosed Ownership
348,083 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
08 Sep 2025, 17:43:43 UTC
Date of event
29 Aug 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Invus Global Management, LLC disclosed 10% ownership in vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT) on 29 Aug 2025."

Quick Takeaways

  • Invus Global Management, LLC filed SCHEDULE 13G for vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT).
  • Disclosed ownership: 10%.
  • Date of event: 29 Aug 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 08 Sep 2025, 17:43.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.8% 306,313 306,313 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.8% 306,313 306,313 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.8% 306,313 306,313 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.8% 306,313 306,313 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 1.3% 41,770 41,770 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 1.3% 41,770 41,770 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 1.3% 41,770 41,770 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 10% 348,083 348,083 0 /s/ Raymond Debbane Raymond Debbane

Sponsored